About Dr. Raghav Sundar
- With +11 years of experience, Dr. Raghav Sundar is a Medical Oncologist.
- His interests are Precision Oncology and Biomarker Development, Gastrointestinal Cancers, Early Phase Drug Development, and Chemotherapy Induced Peripheral Neuropathy.
- He is a member of the Academy of Medicine, Singapore, the Singapore Society of Oncology and the Singapore Medical Association.
- Dr. Raghav Sundar has completed his MBBS and M.Med from the National University of Singapore, Singapore.
- He received MRCP (UK).
- He is the author of various papers and publications.
- Dr. Raghav Sundar is well-versed in English and Malay.
Location
Singapore, SingaporeSpecial Interest
Gastrointestinal oncology.
List Of Treatments
- Metastatic Tumors Treatment
- Chemotherapy
- Adrenal Cancer Treatment
- Anal Cancer Treatment
- Bile Duct Cancer Treatment
- Bladder Cancer Treatment
- Breast Cancer-Surgical
- Cancer in Children
- Carcinoma of Unknown Primary (CUP) Treatment
- Castleman Disease Treatment
- Cervical Cancer Treatment
- Endometrial Cancer Treatment
- Esophagus Cancer Treatment
- Ewing Family of Tumors Treatment
- Eye Cancer Treatment
- Gallbladder Cancer Treatment
- Gestational Trophoblastic Disease (GTD) Treatment
- Hodgkin Disease Treatment
- Laryngeal and Hypopharyngeal Cancer Treatment
- Acute Lymphocytic Leukemia - ALL in Adults
- Leukemia in Children
- Liver Cancer
- Lung Cancer Treatment
- Non-Small Cell Lung Cancer (NSCLC) Treatment
- Small-cell Carcinoma Treatment
- Lung Carcinoid Tumor Treatment
- Skin Lymphoma Treatment
- Malignant Mesothelioma Treatment
- Nasopharyngeal Cancer Treatment
- Neuroblastoma
- Non-Hodgkin Lymphoma (NHL) Treatment
- Non-Hodgkin Lymphoma In Children
- Oral Cavity and Oropharyngeal Cancer
- Ovarian Cancer Surgery
- Pancreatic Cancer
- Penile Cancer Treatment
- Prostate Cancer-Surgical
- Retinoblastoma (RB) Treatment
- Rhabdomyosarcoma (RMS) Treatment
- Salivary Gland Cancer
- Soft Tissue Sarcoma Treatment
- Skin Cancer
- Skin Cancer - Melanoma
- Stomach Cancer Treatment
- Testicular Cancer Treatment
- Thymoma and Thymic Carcinoma Treatment
- Thyroid Cancer Treatment
- Uterine Sarcoma
- Vaginal Cancer Treatment
- Vulvar Cancer Treatment
- Waldenstrom Macroglobulinemia
- Wilms Tumor (Nephroblastoma)
- Breast Biopsy
- Pediatric Bone Marrow Transplant
- Oral Cancer - Surgical
- Breast Cancer
- Leukemia Treatment
- Hairy Cell Leukemia - HCL
- Fallopian Tube Cancer
- Ovarian Germ Cell Tumor
- Ovarian Primary Peritoneal Cancer
- Medullary Carcinoma
- Papillary Thyroid Cancer Treatment
- Ovarian Sex Cord Stromal Tumor
- Invasive Lobular Carcinoma
- Colon Cancer Treatment
- Adenocarcinoma - Glandular Cancer Treatment
- Immunotherapy
- Parathyroidectomy
Work Experience of Dr. Raghav Sundar
Dr. Raghav Sundar's
- MBBS, National University of Singapore, Singapore
- MRCP, UK
- NUHS Mochtar Riady Pinnacle Award Young Achiever (2022) - National University of Singapore - Too Joon Chew PhD Prize - Singapore Medical Association Charity Fund Outstanding Mentor Award (2022) - National University of Singapore Yong Loo Lin School of Medicine Best Graduate Research Publication Award (2021) – NUS - National Medical Research Council Transition Award (2021)
- Integration of Genomic Biology Into Therapeutic Strategies of Gastric Cancer Peritoneal Metastasis. Gwee YX, Chia DKA, So J, Ceelen W, Yong WP, Tan P, Ong CJ, Sundar R. J Clin Oncol. 2022 Aug 20;40(24):2830. (Impact Factor: 51)
- Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis. Lee ARYB, Wong SY, Chai LYA, …, Tan BKJ, Chan YH, Sundar R*, Soon YY. BMJ. 2022 Mar 2;376:e068632. *corresponding author (Impact Factor: 93)
- Low PD-L1 Expressing Subgroup Outcomes of First-Line Immune Checkpoint Inhibitors in Gastric or Escophageal Adenocarcinoma. Zhao JJ., Yap WT, Chan YK, Tan BKJ, Teo CB, Syn NL, Smyth EC, Soon YY, Sundar R. J Clin Oncol. 2022 Feb 1;40(4):392-402. (Impact Factor: 51)
- Single-cell atlas of lineage states, tumor microenvironment and subtype-specific expression programs in gastric cancer. Kumar V*, Ramnarayanan K*, Sundar R*, Padmanbahan N*, …, Tan P. Cancer Discov. 2022 Mar 1;12(3):670-691. *Joint first authors (Impact Factor: 40)
- Epigenetic promoter alterations in GI tumour immune-editing and resistance to immune checkpoint inhibition. Sundar R*, Huang KK, Kumar V, Ramnarayanan K, …, Tan P*. Gut. 2022 Jul;71(7):1277-1288. *joint corresponding (Impact Factor: 32)
(Get Free opinion, Quote, Medical Visa Invitation and Assistance at every step of your treatment.)
Doctor Similar to Dr. Raghav Sundar in Singapore
Medical Oncologist
Senior Consultant
FRCP,MBBS
Singapore, Singapore
40 years of experience
Medical Oncologist
Senior Consultant
MD,MRCP
Singapore, Singapore
26 years of experience
Medical Oncologist
Senior Consultant
MD
Singapore, Singapore
28 years of experience
Medical Oncologist
Senior Consultant
MBBS,MRCP
Singapore, Singapore
30 years of experience
Medical Oncologist
Senior Consultant
MD
Singapore, Singapore
24 years of experience
Medical Oncologist
Senior Consultant
Graduation
Singapore, Singapore
25 years of experience
Medical Oncologist
Senior Consultant
MD
Singapore, Singapore
20 years of experience
Medical Oncologist
Consultant
Graduation
Singapore, Singapore
24 years of experience
Medical Oncologist
Consultant
MBBS
Singapore, Singapore
20 years of experience
Medical Oncologist
Senior Consultant
FRCP,MBBS,MRCP
Singapore, Singapore
19 years of experience
Medical Oncologist
Consultant
Graduation
Singapore, Singapore
22 years of experience
Medical Oncologist
Consultant
FRCP,MBBS,MRCP
Singapore, Singapore
16 years of experience
Medical Oncologist
Senior Consultant
MBBS,MD
Singapore, Singapore
16 years of experience
Medical Oncologist
Consultant
Graduation,MRCP
Singapore, Singapore
20 years of experience
Medical Oncologist
Consultant
FRCP,MBBS
Singapore, Singapore
16 years of experience
Medical Oncologist
Associate Consultant
MBBS,MRCP
Singapore, Singapore
15 years of experience
Medical Oncologist
Consultant
MBBS,MRCP
Singapore, Singapore
12 years of experience
Medical Oncologist
Consultant
MBBS,MRCP
Singapore, Singapore
12 years of experience
Medical Oncologist
Associate Consultant
MBBS,MRCP
Singapore, Singapore
12 years of experience
Medical Oncologist
Consultant
MBBS,MRCP
Singapore, Singapore
10 years of experience
Medical Oncologist
Consultant
MBBS
Singapore, Singapore
10 years of experience
Medical Oncologist
Consultant
Graduation
Singapore, Singapore
10 years of experience
Medical Oncologist
Consultant
MBBS,MRCP
Singapore, Singapore
8 years of experience
Medical Oncologist
Consultant
MBBS,MRCP
Singapore, Singapore
10 years of experience
Medical Oncologist
Consultant
MBBS,MRCP
Singapore, Singapore
12 years of experience
Medical Oncologist
Consultant
MBBS,MRCP
Singapore, Singapore
12 years of experience
Medical Oncologist
Consultant
MBBS,MRCP
Singapore, Singapore
14 years of experience
Medical Oncologist
Associate Consultant
MBBS,MRCP
Singapore, Singapore
16 years of experience
Medical Oncologist
Senior Consultant
MBBS
Singapore, Singapore
18 years of experience
Medical Oncologist
Senior Consultant
MBBS,MRCP
Singapore, Singapore
20 years of experience
Medical Oncologist
Senior Consultant
Diploma,MBBS,MRCP
Singapore, Singapore
20 years of experience
Medical Oncologist
Senior Consultant
MBBS,MRCP
Singapore, Singapore
25 years of experience
Medical Oncologist
Senior Consultant
MBBS
Singapore, Singapore
30 years of experience
Medical Oncologist
Senior Consultant
MBBS,MRCP
Singapore, Singapore
30 years of experience
Medical Oncologist
Senior Consultant
MBBS,MRCP
Singapore, Singapore
30 years of experience
Medical Oncologist
Senior Consultant
FRCP,MBBS,MRCP
Singapore, Singapore
30 years of experience
Medical Oncologist
Consultant
MBBS,MRCP
Singapore, Singapore
20 years of experience
Medical Oncologist
Consultant
Fellowship
Singapore, Singapore
20 years of experience
Medical Oncologist
Consultant
Graduation,MRCP
Singapore, Singapore
25 years of experience